Patients with advanced prostate cancer who received more intensive treatment experienced worse quality of life at three months, but better overall in the long-term, according to a new Northwestern Medicine study.
Deputy Director Maha Hussain, MD oversees clinical research at the Lurie Cancer Center, but never forgets her primary goal: having an impact on patients.
Maha Hussain, MD, recently published several papers detailing new findings in metastatic castration-resistant prostate cancer treatment and prostate cancer screening.
Younger men with prostate cancer had a decreased risk of cancer progression while under active surveillance, compared to men older than 60, according to a recent study.
A combination of ultrasound and cystoscopy is the most cost-effective approach to detecting cancer in patients who show microscopic amounts of blood in their urine, according to a JAMA Internal Medicine study.
In a retrospective study, scientists developed and validated a gene expression signature that can predict which patients with prostate cancer will benefit most from postoperative radiotherapy.